Analystreport

Evofem Biosciences, Inc. (NASDAQ: EVFM) had its price target raised by analysts at Morgan Stanley from $0.50 to $0.53. They now have an "underweight" rating on the

Evofem Biosciences, Inc.  (EVFM) 
Last evofem biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: evofem.com